Tumour Genotype and Response to Cytotoxic Gene Therapy
- 1 January 2002
- book chapter
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Relevance of Ki-67 antigen expression and K- ras mutation in colorectal liver metastasesEuropean Journal of Surgical Oncology, 2001
- Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistanceCancer Letters, 2000
- Cell death beyond apoptosisLeukemia, 2000
- Gap junctions: the “kiss of death” and the “kiss of life”Brain Research Reviews, 2000
- Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cellsCancer Gene Therapy, 1999
- CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanismExperimental Hematology, 1999
- Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector Containing theE. coliCytosine Deaminase Gene to Metastatic Colon Carcinoma of the Liver in Association with the Oral Administration of the Pro-Drug 5-Fluorocytosine. The New York Hospital-Cornell Medical Center, New York, NYHuman Gene Therapy, 1997
- Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.The Journal of Experimental Medicine, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- The Role of APO‐1‐Mediated Apoptosis in the Immune SystemImmunological Reviews, 1994